ZCA
BSX icon

Zeke Capital Advisors’s Boston Scientific BSX Stock Holding History

Zeke Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$420K Sell
9,073
-1
-0% -$43 0.03% 270
2022
Q3 		$351K Sell
9,074
-123
-1% -$4.93K 0.03% 279
2022
Q2 		$343K Sell
9,197
-84
-0.9% -$3.42K 0.02% 290
2022
Q1 		$411K Buy
+9,281
New +$402K 0.02% 272
2020
Q1 		– Sell
-19,385
Closed -$877K – 275
2019
Q4 		$877K Sell
19,385
-395
-2% -$16.5K 0.07% 233
2019
Q3 		$805K Buy
19,780
+1,200
+6% +$50.8K 0.07% 246
2019
Q2 		$799K Sell
18,580
-2,231
-11% -$85.8K 0.08% 235
2019
Q1 		$799K Sell
20,811
-1,160
-5% -$44.3K 0.07% 234
2018
Q4 		$776K Sell
21,971
-4,670
-18% -$169K 0.07% 248
2018
Q3 		$1.03M Hold
26,641
– – 0.08% 243
2018
Q2 		$871K Buy
26,641
+599
+2% +$18.1K 0.08% 209
2018
Q1 		$711K Buy
26,042
+15,754
+153% +$428K 0.07% 267
2017
Q4 		$255K Sell
10,288
-18,634
-64% -$514K 0.03% 429
2017
Q3 		$844K Buy
28,922
+19,895
+220% +$549K 0.12% 138
2017
Q2 		$250K Hold
9,027
– – 0.05% 231
2017
Q1 		$225K Buy
+9,027
New +$220K 0.05% 232

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Zeke Capital Advisors's BSX Position: Q4 2022 in Review

Zeke Capital Advisors reduced its Boston Scientific (BSX) stake by 0.01% in Q4 2022, selling an estimated $43 and leaving 9,073 shares worth $420K. The position accounts for 0.03% of the portfolio, ranked #270.

Zeke Capital Advisors first reported a position in BSX in Q1 2017 and has held it in 16 quarters since. The position peaked at $1.03M in Q3 2018. 929 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Zeke Capital Advisors held 9,073 shares of Boston Scientific worth $420K as of Q4 2022.
  • Zeke Capital Advisors sold 1 Boston Scientific share in Q4 2022, an estimated $43.
  • Boston Scientific made up 0.03% of Zeke Capital Advisors's portfolio in Q4 2022, its #270 holding.
  • Zeke Capital Advisors first reported a position in Boston Scientific in Q1 2017 and has held it in 16 quarters since.
  • Zeke Capital Advisors's Boston Scientific position peaked at $1.03M in Q3 2018.
  • 929 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.